ampligen

  1. Sly Saint

    Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

    Several posts have been moved from this thread: Ampligen - Hemispherx Biopharma re ME/CFS not relating to ME but Covid-19 AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus...
    • Sly Saint
    • Thread
    • aim ampligen double-blind phase ii randomized controlled trial rintatolimod
    • Replies: 36
    • Forum: Long Covid research
  2. cassava7

    A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of CFS, Strayer et al, 2012

    Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod...
    • cassava7
    • Thread
    • ampligen phase iii randomized controlled trial rct rintatolimod
    • Replies: 15
    • Forum: ME/CFS research
  3. ME/CFS Skeptic

    The most promising drugs for ME/CFS?

    With EMEC we are trying to set up a meeting with representatives of The European Federation of Pharmaceutical Industries and Associations (EFPIA). We are compiling a list of drugs that seem most promising for the treatment of ME/CFS and the pharmaceutical companies that make them. An example...
  4. Andy

    Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for [ME/CFS], 2020, Mitchell et al

    Rintatolimod = Ampligen Open access, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240403
    • Andy
    • Thread
    • 2020 ampligen me/cfs paper rintatolimod
    • Replies: 16
    • Forum: ME/CFS research
  5. Sly Saint

    A Controlled Clinical Trial with a Specifically Configured RNA Drug, Poly(I). POly(C12U), in Chronic Fatigue Syndrome - 1994 Strayer, Cheney et al

    Clinical Infectious Diseases, Volume 18, Issue Supplement_1, January 1994, Pages S88–S95, https://doi.org/10.1093/clinids/18.Supplement_1.S88 Published: 01 January 1994 https://academic.oup.com/cid/article-abstract/18/Supplement_1/S88/317068?redirectedFrom=fulltext...
    • Sly Saint
    • Thread
    • 1994 ampligen cheney clinical trial objective measure paper poly(i) rna strayer treatment
    • Replies: 1
    • Forum: ME/CFS research
  6. rvallee

    Discussion of documentary: What about ME? (2016)

    Two days ago I was made aware of a documentary titled "What about ME?", published in 2016. First time I had heard of it and maybe I missed discussion at the time since I wasn't around here but there does not appear to be any discussions on it yet, none that Google could find anyway (since the...
  7. John Mac

    New Yorker: A Town for People with Chronic Fatigue Syndrome

    Article on the New Yorker Website about Incline Village and Ampligen. https://www.newyorker.com/culture/personal-history/a-town-for-people-with-chronic-fatigue
  8. Viola

    USA: News from Simmaron Research foundation

    Vote to get money for Simmaron Research foundation (free and easy) Hi everyone, this came up on my Facebook. I don't know how long it is going to go on for. It involves daily voting, but any votes would be good. It is very easy. You just click on the link below, then after a few seconds a box...
  9. Sly Saint

    Ampligen for ME/CFS

    "PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017." "We have secured our first country approval for Ampligen® in ME/CFS and we expect several more in the coming years."...
  10. Sasha

    Pharma industry newsletter on ME/CFS drugs ('Pink Sheet') - Ampligen, Rituxan and KPAX-002

    This is some sort of industry newsletter, and Zaher Nahle of Solve spoke with the people who produce it...
Back
Top Bottom